Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-015246
Filing Date
2026-05-06
Accepted
2026-05-06 17:00:48
Documents
67
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tgtx20260331_10q.htm   iXBRL 10-Q 1655695
2 EXHIBIT 10.1 ex_944322.htm EX-10.1 1193792
3 EXHIBIT 31.1 ex_926559.htm EX-31.1 12340
4 EXHIBIT 31.2 ex_926560.htm EX-31.2 12684
5 EXHIBIT 32.1 ex_926561.htm EX-32.1 5722
6 EXHIBIT 32.2 ex_926562.htm EX-32.2 6039
  Complete submission text file 0001437749-26-015246.txt   8570114

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20260331.xsd EX-101.SCH 55609
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20260331_cal.xml EX-101.CAL 46486
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20260331_def.xml EX-101.DEF 396875
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20260331_lab.xml EX-101.LAB 363860
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20260331_pre.xml EX-101.PRE 427113
71 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20260331_10q_htm.xml XML 937270
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 26949519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)